BioLineRx Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $25.3M | $47.3M | $16.8M |
| FY2021 | $13.3M | $81.4M | $13.0M |
| FY2022 | $25.5M | $76.4M | $10.6M |
| FY2023 | $50.7M | $63.9M | $4.3M |
| FY2024 | $25.4M | $38.9M | $10.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $25.3M | $47.3M | $16.8M |
| FY2021 | $13.3M | $81.4M | $13.0M |
| FY2022 | $25.5M | $76.4M | $10.6M |
| FY2023 | $50.7M | $63.9M | $4.3M |
| FY2024 | $25.4M | $38.9M | $10.4M |